abstract |
A formulation comprises a plurality of seamless minicapsules, the minicapsules having a diameter of from 0.5 mm to 5 mm, the minicapsules having a core containing an active entity and an encapsulating body, the active entity being in the form of any one or more of: a microemulsion, a nanoemulsion, a self-emulsifying delivery system, a self-microemulsifying delivery system, a biostable perflurocarbon formulation, a complex with cyclodextrin (and the like), liposomes, hydrogel, lymphatic targeted delivery system, liquid bi-layers, an aqueous System, wax, emzaloid, and natural plant extract. |